Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENDP
4326
PUT
DELISTED
Endo International plc
ENDP
| $1.14M | ﹤0.01% |
146,900
+103,600
| +239% | +$775K |
|
4327
PUT
Element Solutions
ESI
$9.46B
| $1.14M | ﹤0.01% |
114,600
+102,200
| +824% | +$1.06M |
|
|
ANH
4328
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $1.14M | ﹤0.01% |
209,094
-151,593
| -42% | -$865K |
|
4329
CALL
UFP Industries
UFPI
$4.96B
| $1.14M | ﹤0.01% |
30,200
+8,300
| +38% | +$305K |
|
4330
iShares Currency Hedged MSCI Japan ETF
HEWJ
$766M
| $1.13M | ﹤0.01% |
33,999
-107,421
| -76% | -$3.51M |
|
4331
Hovnanian Enterprises
HOV
$785M
| $1.13M | ﹤0.01% |
13,523
-12,211
| -47% | -$755K |
|
4332
St. Joe Company
JOE
$3.89B
| $1.13M | ﹤0.01% |
62,767
+6,657
| +12% | +$123K |
|
4333
PUT
Jones Lang LaSalle
JLL
$17.3B
| $1.13M | ﹤0.01% |
7,600
+5,700
| +300% | +$806K |
|
4334
E.W. Scripps
SSP
$320M
| $1.13M | ﹤0.01% |
72,472
-34,441
| -32% | -$558K |
|
4335
Quanex
NX
$962M
| $1.13M | ﹤0.01% |
48,330
-4,529
| -9% | -$100K |
|
|
EMES
4336
DELISTED
Emerge Energy Services LP
EMES
| $1.13M | ﹤0.01% |
156,676
+94,098
| +150% | +$736K |
|
|
WPZ
4337
PUT
DELISTED
Williams Partners L.P.
WPZ
| $1.13M | ﹤0.01% |
29,000
-11,600
| -29% | -$435K |
|
4338
Griffon
GFF
$4.72B
| $1.12M | ﹤0.01% |
55,214
+11,539
| +26% | +$252K |
|
4339
Mercer International
MERC
$31.6M
| $1.12M | ﹤0.01% |
78,540
+46,353
| +144% | +$636K |
|
|
MRSH
4340
CALL
Marsh
MRSH
$89.6B
| $1.12M | ﹤0.01% |
13,800
+5,100
| +59% | +$424K |
|
4341
PUT
Reinsurance Group of America
RGA
$16.3B
| $1.12M | ﹤0.01% |
7,200
+2,500
| +53% | +$379K |
|
4342
Ecolab
ECL
$77.4B
| $1.12M | ﹤0.01% |
+8,365
| New | +$1.11M |
|
4343
PUT
Quanta Services
PWR
$103B
| $1.12M | ﹤0.01% |
28,700
-3,800
| -12% | -$143K |
|
|
ESV
4344
PUT
DELISTED
Ensco Rowan plc
ESV
| $1.12M | ﹤0.01% |
47,475
+8,650
| +22% | +$192K |
|
4345
CALL
STMicroelectronics
STM
$48.5B
| $1.12M | ﹤0.01% |
51,300
-45,100
| -47% | -$998K |
|
4346
CALL
BWX Technologies
BWXT
$15.9B
| $1.12M | ﹤0.01% |
18,500
+6,900
| +59% | +$416K |
|
|
KERX
4347
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $1.12M | ﹤0.01% |
240,672
+89,889
| +60% | +$495K |
|
|
NRE
4348
DELISTED
NorthStar Realty Europe Corp.
NRE
| $1.12M | ﹤0.01% |
83,222
+54,453
| +189% | +$753K |
|
4349
CALL
TG Therapeutics
TGTX
$7.46B
| $1.11M | ﹤0.01% |
136,000
+39,400
| +41% | +$344K |
|
4350
PUT
Broadridge
BR
$19.5B
| $1.11M | ﹤0.01% |
+12,300
| New | +$1.07M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.